Breaking News Instant updates and real-time market news.

MDB

MongoDB

$38.72

-1.48 (-3.68%)

, SEND

SendGrid

$29.64

-0.71 (-2.34%)

10:13
03/24/18
03/24
10:13
03/24/18
10:13

Barron's lists potential takeover targets in cloud software

Shares of young cloud software companies like MongoDB (MDB) and SendGrid (SEND) have soared since the Nasdaq's bottom on February 8, in part on speculation of a takeover, Barron's Tiernan Ray contends. Takeover targets form a long list in addition to the aforementioned, and include Friday's initial public offering Dropbox (DBX), Appian (APPN), Veeva Systems (VEEV), Atlassian (TEAM) and ServiceNow (NOW), Ray writes. Reference Link

MDB

MongoDB

$38.72

-1.48 (-3.68%)

SEND

SendGrid

$29.64

-0.71 (-2.34%)

DBX

Dropbox

$28.48

14.86 (109.10%)

APPN

Appian

$26.26

-0.11 (-0.42%)

VEEV

Veeva

$74.30

-0.78 (-1.04%)

TEAM

Atlassian

$55.36

-2.15 (-3.74%)

NOW

ServiceNow

$164.77

-3.99 (-2.36%)

  • 25

    Mar

  • 11

    Apr

  • 23

    Mar

MDB MongoDB
$38.72

-1.48 (-3.68%)

03/14/18
LEHM
03/14/18
NO CHANGE
Target $45
LEHM
Overweight
MongoDB price target raised to $45 from $38 at Barclays
Barclays analyst Raimo Lenschow raised his price target for MongoDB to $45 saying the company's "strong" Q4 results strengthen his view that the shares will continue to work well for investors. The analyst is encouraged by the pickup in large deal activity, traction in Atlas as well as the progress the company is showing on the technological front. He keeps an Overweight rating on the shares.
03/14/18
NEED
03/14/18
NO CHANGE
Target $43
NEED
Buy
MongoDB price target raised to $43 from $34 at Needham
Needham analyst Jack Andrews raised his price target on MongoDB to $43 after the company's Q4 earnings beat along with FY19 guidance that was above consensus. Andrews points to "continued indications of replatforming by customers, strong customer and deal metrics, and strengthening of the partner ecosystem" as the positives of the earnings report and believes the company is an "emerging industry leader" attacking a large addressable market. The analyst keeps his Buy rating on MongoDB, adding that the departure of its Chief Revenue Officer will have a muted impact.
03/14/18
STFL
03/14/18
NO CHANGE
Target $43
STFL
Buy
MongoDB price target raised to $43 from $34 at Stifel
Stifel analyst Brad Reback said MongoDB's second quarterly report as a public company "once again" saw all of the company's key financial metrics top consensus estimates. Noting that management remains bullish around the company's ability to capture share and gave FY19 guidance above the Street view, Reback said he remains a buyer of MongoDB and raised his price target on the stock to $43.
03/14/18
ADAM
03/14/18
NO CHANGE
Target $45
ADAM
Buy
MongoDB price target raised to $45 from $35 at Canaccord
Canaccord analyst Richard Davis raised his price target on MongoDB to $45 from $35 following good Q4 results. The analyst admitted the shares were highly valued in an expensive sector, but he said owning some of the stock today will prove to be a very wise investment tomorrow. He said software is a business in which scale begets more growth and leads to exponential separation from the competition. Davis reiterated his Buy rating on MongoDB shares.
SEND SendGrid
$29.64

-0.71 (-2.34%)

12/11/17
MSCO
12/11/17
INITIATION
Target $23
MSCO
Equal Weight
SendGrid initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Stan Zlotsky started SendGrid with an Equal Weight rating and $23 price target, saying he sees many attractive facets to its story, but that but much of it is already priced into the stock at current levels.
02/27/18
STFL
02/27/18
NO CHANGE
Target $30
STFL
Buy
SendGrid issued 'convincing beat' in first public report, says Stifel
Stifel analyst Tom Roderick said SendGrid's first quarterly report as a public company was "a convincing beat on all key metrics," including revenue, adjusted income, email volumes and customer count. Roderick, who sees the company executing well across its growth strategy and expects that trend to continue, raised his price target on SendGrid shares to $30 from $25 and keeps a Buy rating on the stock.
02/27/18
KEYB
02/27/18
NO CHANGE
Target $32
KEYB
Overweight
SendGrid price target raised to $32 from $26 at KeyBanc
KeyBanc analyst Brent Bracelin raised his price target fro SendGrid to $32 from $26 after the company delivered a "solid" first quarter as a public company with upside across all growth and profitability metrics. The analyst reiterates an Overweight rating on the shares.
12/11/17
12/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Market Perform on valuation at Cowen. 2. Illinois Tool Works (ITW) initiated with a Buy at BofA/Merrill. 3. SendGrid (SEND) was initiated with an Outperform at William Blair, an Overweight at Piper Jaffray, KeyBanc, and JPMorgan, a Buy at Stifel, as well as an Equal Weight at Morgan Stanley. 4. BWX Technologies (BWXT) initiated with a Market Perform at Wells Fargo. 5. Arsanis (ASNS) was initiated with an Overweight at Piper Jaffray, an Outperform at Cowen, and a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
DBX Dropbox
$28.48

14.86 (109.10%)

03/21/18
DADA
03/21/18
INITIATION
Target $22
DADA
Buy
Dropbox initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Dropbox with a Buy rating and a price target of $22 following the company's IPO pricing. Jaluria says that Dropbox offers a "differentiated strategy, rapid growth, strong cash flow margins, and a reasonable valuation". The analyst is also positive on the company's low marketing expenses thanks to its 90% of overall revenues coming from self-serve channels as well as becoming the second fastest technology company to reach $1B in revenues in just 11 years.
03/21/18
03/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Celgene (CELG) reinstated with an Overweight at JPMorgan. 2. ConvergeOne (CVON) initiated with a Buy at BTIG. 3. Dropbox (DBX) initiated with a Buy at DA Davidson. 4. Diffusion Pharmaceuticals (DFFN) initiated with a Buy at H.C. Wainwright. 5. Xcerra (XCRA) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
APPN Appian
$26.26

-0.11 (-0.42%)

01/18/18
GSCO
01/18/18
DOWNGRADE
Target $20
GSCO
Sell
Appian downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Jesse Hulsing downgraded Appian to Sell with an unchanged price target of $20. The stock since December 17 has rallied 80% on no company specific news or major change in the macro environment, Hulsing tells investors in a research note. The analyst believes the rally is not justified based on company fundamentals.
03/12/18
BTIG
03/12/18
INITIATION
BTIG
Neutral
Appian initiated with a Neutral at BTIG
BTIG analyst Joel P. Fishbein, Jr. started Appian with a Neutral rating, stating that while its fundamentals are "some of the best in SaaS," the stock's "rich" valuation seems to ignore the fact that much of its revenue is still from professional services and the company is more than 3 years out from generating meaningful cash flow.
01/19/18
WBLR
01/19/18
DOWNGRADE
WBLR
Market Perform
Appian downgraded to Market Perform from Outperform at William Blair
William Blair analyst Bhavan Suri downgraded Appian to Market Perform citing valuation ahead the company's Q4 results, which he expects will be "solid."
03/12/18
03/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. LiveXLive Media (LIVX) initiated with an Outperform at JMP Securities. 2. Americold Realty Trust (COLD) initiated with a Neutral at Goldman Sachs. 3. Motus GI Holdings (MOTS) initiated with an Overweight at Piper Jaffray and an Outperform at Oppenheimer. 4. Fennec (FENC) initiated with an Outperform at Wedbush. 5. Appian (APPN) initiated with a Neutral at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
VEEV Veeva
$74.30

-0.78 (-1.04%)

03/23/18
JMPS
03/23/18
NO CHANGE
Target $80
JMPS
Outperform
Veeva price target raised to $80 at JMP Securities after management meetings
JMP Securities analyst Patrick Walravens raised his price target on Veeva Systems to $80 from $74 and maintained his Outperform rating after meeting with executives including co-founder and president Matt Wallach this week. In a research note to investors, Walravens said that the overall business tone at Veeva "sounds great," adding that the competitive set appears to "remain relatively benign" and that the development cloud across Vault is "really working" this year. Additionally, the analyst said QualityOne represents Veeva's entry into the world outside of life sciences longer-term, which could represent a total addressable market that exceeds the entire life sciences Vault TAM of $4B over time.
02/21/18
MSCO
02/21/18
NO CHANGE
Target $72
MSCO
Overweight
Veeva checks suggest strong Vault momentum in Q4, says Morgan Stanley
Morgan Stanley analyst Stan Zlotsky said his Q4 checks on Veeva made him incrementally more positive on the sustainability of Vault's growth entering FY19. Along with healthy underlying trends, he also sees upside to conservative FY19 estimates, said Zlotsky, who keeps an Overweight rating and $72 price target on Veeva shares ahead of the company's Q4 report next week.
02/28/18
ADAM
02/28/18
NO CHANGE
Target $75
ADAM
Buy
Veeva price target raised to $75 from $70 at Canaccord
Canaccord analyst Richard Davis raised his price target on Veeva to $75 from $70 citing its better than expected Q4 results. The analyst said the company has several growth initiatives in process that range from significant new feature upsells to adjacent customer breadth moves. Davis, who believes investors will eventually figure out the shares could move sustainably higher, reiterated his Buy rating on Veeva shares.
03/09/18
JPMS
03/09/18
DOWNGRADE
Target $77
JPMS
Neutral
Veeva downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Sterling Auty downgraded Veeva Systems to Neutral with an unchanged price target of $77. The analyst is making a valuation call with the shares up 40% year-to-date. He sees "limited room for outperformance" from current share levels, but believes Veeva is executing well on a number of growth initiatives.
TEAM Atlassian
$55.36

-2.15 (-3.74%)

01/19/18
JEFF
01/19/18
NO CHANGE
Target $64
JEFF
Buy
Atlassian price target raised to $64 from $53 at Jefferies
Jefferies analyst John DiFucci raised his price target for Atlassian to $64 saying the company's Q2 results show continued momentum. The analyst keeps a Buy rating on the shares.
01/19/18
MSCO
01/19/18
NO CHANGE
Target $63
MSCO
Overweight
Morgan Stanley says 'more to come' from Atlassian after 'impressive' Q2
Morgan Stanley analyst Sanjit Singh noted that Atlassian's Q2 marks the second quarter in a row that revenue growth accelerated to above 40%. He sees "more to come" from Atlassian, as he thinks not only will FY18 guidance prove conservative but that its outperformance relative to consensus can go on into FY19, Singh tells investors. The analyst maintains an Overweight rating on Atlassian shares and raised his price target on the stock to $63 from $61.
01/19/18
BMOC
01/19/18
NO CHANGE
Target $56
BMOC
Market Perform
Atlassian price target raised to $56 from $51 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Atlassian to $56 after earnings that marked a "good quarter all around". Bachman notes that the management's guidance also appears to be conservative, with the company's solid positioning as a provider of group workflow amid the "changing nature of work". The analyst keeps his Market Perform rating, adding that the risk/reward is not attractive based on the current valuation.
01/19/18
BARD
01/19/18
NO CHANGE
Target $56
BARD
Outperform
Atlassian weakness would be a buying opportunity, says Baird
Baird analyst Rob Oliver said Atlassian reported solid Q2 results, citing its revenue acceleration, better than expected billings, record number of customer additions, and margins ahead of expectations. The analyst said the shares are priced for perfection, but that any pullback would be a buying opportunity. Oliver reiterated his Outperform rating and raised his price target to $56 from $50 on Atlassian shares.
NOW ServiceNow
$164.77

-3.99 (-2.36%)

02/20/18
LEHM
02/20/18
NO CHANGE
Target $180
LEHM
Overweight
ServiceNow price target raised to $180 from $158 at Barclays
Barclays analyst Raimo Lenschow raised his price target for ServiceNow to $180 saying the company is not just a play on the IT Service Management market, but a platform offering that can address workflows in all parts of the enterprise. Many investors still do not understand ServiceNow very well, Lenschow tells investors in a research note. The analyst sees "meaningful upside" to the company's long-term guidance and keeps an Overweight rating on the shares.
03/19/18
KEYB
03/19/18
NO CHANGE
Target $194
KEYB
Overweight
ServiceNow price target raised to $194 from $165 at KeyBanc
KeyBanc analyst Rob Owens raised his price target for ServiceNow to $194 from $165 on valuation. The analyst reiterates an Overweight rating on the shares.
03/01/18
UBSW
03/01/18
NO CHANGE
Target $180
UBSW
Buy
ServiceNow among most attractive core holdings in software, says UBS
UBS analyst Jennifer Lowe said ServiceNow remains one of the most attractive core holdings in software despite the year-to-date move in the stock price. The analyst believes earnings beats can power the near-term stock performance while longer term performance is supported by one of the strongest combos of growth and profitability in software. Lowe reiterated her Buy rating and $180 price target on ServiceNow shares.
03/13/18
ARGS
03/13/18
NO CHANGE
Target $201
ARGS
Buy
ServiceNow price target raised to $201 from $170 at Argus
Argus analyst Joseph Bonner raised his price target on ServiceNow to $201, saying the company offers a value proposition to make IT services manageable and efficient. Bonner states that the company is benefiting from secular trends away from enterprise data center and toward the "easily scalable cloud software as a service model". The analyst keeps his Buy rating on ServiceNow, noting that despite the strong run in the stock price, shares are valued favorably by historical standards.

TODAY'S FREE FLY STORIES

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/17/18
11/17
04:55
11/17/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

18:48
11/16/18
11/16
18:48
11/16/18
18:48
Hot Stocks
Motorola Solutions: ITC confirms Hytera products infringe Motorola patents »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:23
11/16/18
11/16
18:23
11/16/18
18:23
Periodicals
CPUC isn't ruling out board shuffle, breakup for PG&E, Bloomberg says »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.04

0.05 (0.38%)

18:00
11/16/18
11/16
18:00
11/16/18
18:00
Periodicals
Barrick Gold looking to add more copper, bullion assets, Reuters reports »

Barrick Gold is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$33.05

0.165 (0.50%)

17:57
11/16/18
11/16
17:57
11/16/18
17:57
Hot Stocks
Aqua America CEO acquires over 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

, XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

17:39
11/16/18
11/16
17:39
11/16/18
17:39
General news
Week ending ETF scorecard: Real Estate leads, Consumer Discretionary slumps »

S&P500 SECTORS: Real…

XLRE

Real Estate SPDR

$33.45

0.445 (1.35%)

XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

XLU

Utilities SPDR

$54.86

0.77 (1.42%)

XLI

Industrial Select Sector SPDR

$72.00

(0.00%)

XLV

Health Care Select Sector SPDR

$92.05

0.91 (1.00%)

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

XLP

Consumer Staples Sector SPDR

$56.04

0.15 (0.27%)

XLE

Energy Select Sector SPDR

$67.23

0.76 (1.14%)

XLC

Communication Services Select Sector SPDR Fund

$44.88

-0.2 (-0.44%)

XLK

Technology Select Sector SPDR

$68.22

-0.1 (-0.15%)

XLY

Consumer Discretionary Sector SPDR

$106.37

-0.43 (-0.40%)

GLD

SPDR Gold Shares

$115.56

0.82 (0.71%)

SLV

iShares Silver Trust

$13.55

0.115 (0.86%)

USO

United States Oil Fund

$12.07

0.08 (0.67%)

UNG

United States Natural Gas Fund

$35.43

3.63 (11.42%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.24

-0.27 (-0.32%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$111.73

0.23 (0.21%)

TLT

iShares 20+ Year Treasury Bond Fund

$114.65

0.61 (0.53%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.13

0.3 (0.30%)

SHY

iShares 1-3 Year Treasury Bond

$83.13

0.08 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$17.02

0.23 (1.37%)

17:36
11/16/18
11/16
17:36
11/16/18
17:36
Hot Stocks
Aquestive receives CRL from FDA for tadalafil oral film »

Aquestive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

DAKT

Daktronics

$7.67

0.07 (0.92%)

17:35
11/16/18
11/16
17:35
11/16/18
17:35
Hot Stocks
Daktronics adopts new shareholder rights agreement »

Daktronics announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TI

Telecom Italia

$6.02

0.12 (2.03%)

17:33
11/16/18
11/16
17:33
11/16/18
17:33
Periodicals
Gubitosi viewed as frontrunner for Telecom Italia CEO job, Reuters says »

Veteran Italian manager…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$18.77

-0.59 (-3.05%)

17:30
11/16/18
11/16
17:30
11/16/18
17:30
Hot Stocks
Maxar Technologies shareholders approve U.S. domestication »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$1.83

(0.00%)

17:28
11/16/18
11/16
17:28
11/16/18
17:28
Syndicate
Breaking Syndicate news story on Plug Power »

Plug Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$4.55

-0.02 (-0.44%)

17:22
11/16/18
11/16
17:22
11/16/18
17:22
Syndicate
Breaking Syndicate news story on GlobalSCAPE »

GlobalSCAPE files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$388.18

2.67 (0.69%)

17:19
11/16/18
11/16
17:19
11/16/18
17:19
Hot Stocks
Equinix's Lee sells 2,792 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

LMT

Lockheed Martin

$301.06

-4.42 (-1.45%)

17:17
11/16/18
11/16
17:17
11/16/18
17:17
Hot Stocks
Lockheed Martin awarded $282.09M Naval Sea Systems Command contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLGT

Teligent

$2.56

0.045 (1.79%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Hot Stocks
Teligent receives notification of deficiency from Nasdaq »

Teligent said that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAF

Staffing 360 Solutions

$1.82

0.07 (4.00%)

17:16
11/16/18
11/16
17:16
11/16/18
17:16
Syndicate
Breaking Syndicate news story on Staffing 360 Solutions »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IMMR

Immersion

$9.56

-0.14 (-1.44%)

17:12
11/16/18
11/16
17:12
11/16/18
17:12
Hot Stocks
Breaking Hot Stocks news story on Immersion »

Man Group reports 4.84%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$11.95

0.74 (6.60%)

17:10
11/16/18
11/16
17:10
11/16/18
17:10
Hot Stocks
Breaking Hot Stocks news story on Athenex »

Perceptive Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 02

    Dec

TSRO

Tesaro

$34.96

8.39 (31.58%)

17:08
11/16/18
11/16
17:08
11/16/18
17:08
Recommendations
Tesaro analyst commentary at Piper Jaffray »

Piper Jaffray says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

EEI

Ecology & Environment

$10.50

-2 (-16.00%)

17:05
11/16/18
11/16
17:05
11/16/18
17:05
Hot Stocks
Ecology & Environment receives noncompliance notice from Nasdaq »

Ecology and Environment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEE

Ameren

$69.29

0.01 (0.01%)

16:58
11/16/18
11/16
16:58
11/16/18
16:58
Hot Stocks
Ameren exec Nelson sells $690,000 worth of common shares »

Ameren SVP, general…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQS

Equus II Inc

$1.86

(0.00%)

16:56
11/16/18
11/16
16:56
11/16/18
16:56
Hot Stocks
Equus II Inc reports net assets of $46.6M as of September 30 »

Equus Total Return…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAPO

Vapotherm

$17.10

-0.42 (-2.40%)

16:56
11/16/18
11/16
16:56
11/16/18
16:56
Hot Stocks
Breaking Hot Stocks news story on Vapotherm »

Redmile Group reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

COTY

Coty

$9.09

0.39 (4.48%)

16:55
11/16/18
11/16
16:55
11/16/18
16:55
Hot Stocks
Coty CEO acquires 2.3M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

NVS

Novartis

$87.74

0.52 (0.60%)

16:54
11/16/18
11/16
16:54
11/16/18
16:54
Upgrade
Novartis rating change at Goldman Sachs »

Novartis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.